BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Weissferdt A, Moran CA. Thymic carcinoma, part 1: a clinicopathologic and immunohistochemical study of 65 cases. Am J Clin Pathol 2012;138:103-14. [PMID: 22706865 DOI: 10.1309/AJCP88FZTWANLRCB] [Cited by in Crossref: 85] [Cited by in F6Publishing: 74] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Weissferdt A. Combined Thymic Epithelial Neoplasms - a Review. Int J Surg Pathol 2022;:10668969221118324. [PMID: 36036356 DOI: 10.1177/10668969221118324] [Reference Citation Analysis]
2 Gillet B, Orbach D, Helfre S, Didon A, Meignin V, Calvani J. Un diagnostic rare de masse médiastinale antérieure chez un jeune de 12 ans. Annales de Pathologie 2022. [DOI: 10.1016/j.annpat.2022.07.026] [Reference Citation Analysis]
3 Huang YY, Liu X, Liang SH, Wu LL, Ma GW. Nomogram predicts the prognosis of patients with thymic carcinoma: A population-based study using SEER data. Tumori 2022;:3008916221109334. [PMID: 35897150 DOI: 10.1177/03008916221109334] [Reference Citation Analysis]
4 Nishii Y, Furuhashi K, Ito K, Sakaguchi T, Suzuki Y, Fujiwara K, Yasuma T, Kobayashi T, D’alessandro-gabazza CN, Gabazza EC, Taguchi O, Hataji O. Good Response of Advanced Thymic Carcinoma with Low PD-L1 Expression to Chemotherapy plus Pembrolizumab as First-Line Therapy and to Pembrolizumab as Maintenance Therapy: A Case Report. Pharmaceuticals 2022;15:889. [DOI: 10.3390/ph15070889] [Reference Citation Analysis]
5 Sutedja EK, Rizqandaru T, Ruchiatan K, Sutedja E. Cutaneous Metastases from Thymic Carcinoma Primary Tumor: A Rare Case. IMCRJ 2022;Volume 15:293-298. [DOI: 10.2147/imcrj.s369726] [Reference Citation Analysis]
6 Gallo E, Ramieri MT, Marino M. Structural and Functional Thymic Biomarkers Are Involved in the Pathogenesis of Thymic Epithelial Tumors: An Overview. Immuno 2022;2:408-29. [DOI: 10.3390/immuno2020025] [Reference Citation Analysis]
7 Alqaidy D, Moran CA. Thymic Carcinoma: A Review. Front Oncol 2022;12:808019. [DOI: 10.3389/fonc.2022.808019] [Reference Citation Analysis]
8 Nakazono T, Yamaguchi K, Egashira R, Iyadomi M, Fujiki K, Takayanagi S, Mizuguchi M, Irie H. MRI Findings and Differential Diagnosis of Anterior Mediastinal Solid Tumors. Magn Reson Med Sci 2022. [PMID: 35296589 DOI: 10.2463/mrms.rev.2021-0098] [Reference Citation Analysis]
9 Weissferdt A. The spectrum of sebaceous differentiation in tumors of thymic origin. Pathology - Research and Practice 2022;229:153702. [DOI: 10.1016/j.prp.2021.153702] [Reference Citation Analysis]
10 Chia JJ, Fishbein GA. Thymic Carcinoma Versus Lung Squamous Cell Carcinoma. Practical Lung Pathology 2022. [DOI: 10.1007/978-3-031-14402-8_20] [Reference Citation Analysis]
11 Shiiya H, Ujiie H, Hida Y, Kato T, Kaga K, Wakasa S, Kikuchi E, Shinagawa N, Okada K, Ito YM, Matsuno Y. Elevated serum CYFRA 21-1 level as a diagnostic marker for thymic carcinoma. Thorac Cancer 2021;12:2933-42. [PMID: 34581013 DOI: 10.1111/1759-7714.14158] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Ose N, Kawagishi S, Funaki S, Kanou T, Fukui E, Kimura K, Minami M, Shintani Y. Thymic Lymphoepithelial Carcinoma Associated with Epstein-Barr Virus: Experiences and Literature Review. Cancers (Basel) 2021;13:4794. [PMID: 34638279 DOI: 10.3390/cancers13194794] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
13 Oramas DM, Moran CA. Thymoma: Challenges and Pitfalls in Biopsy Interpretation. Adv Anat Pathol 2021;28:291-7. [PMID: 34139743 DOI: 10.1097/PAP.0000000000000310] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Soejima S, Kondo K, Tsuboi M, Muguruma K, Tegshee B, Kawakami Y, Kajiura K, Kawakita N, Toba H, Yoshida M, Takizawa H, Tangoku A. GAD1 expression and its methylation as indicators of malignant behavior in thymic epithelial tumors. Oncol Lett 2021;21:483. [PMID: 33968199 DOI: 10.3892/ol.2021.12744] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
15 Laan M, Salumets A, Klein A, Reintamm K, Bichele R, Peterson H, Peterson P. Post-Aire Medullary Thymic Epithelial Cells and Hassall's Corpuscles as Inducers of Tonic Pro-Inflammatory Microenvironment. Front Immunol 2021;12:635569. [PMID: 33868260 DOI: 10.3389/fimmu.2021.635569] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Li M, Pu XY, Dong LH, Chang PY. Metastatic thymic-enteric adenocarcinoma responding to chemoradiation plus anti-angiogenic therapy: A case report. World J Clin Cases 2021; 9(7): 1676-1681 [PMID: 33728312 DOI: 10.12998/wjcc.v9.i7.1676] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Knetki-Wróblewska M, Kowalski DM, Olszyna-Serementa M, Krzakowski M, Szołkowska M. Thymic epithelial tumors: Do we know all the prognostic factors? Thorac Cancer 2021;12:339-48. [PMID: 33386778 DOI: 10.1111/1759-7714.13750] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
18 Yang X, Zhao K, Li C, Yang Y, Guo C, Pu Y, Liu L. Thymic Squamous Cell Carcinoma: A Population-Based Surveillance, Epidemiology, and End Result Analysis. Front Oncol 2020;10:592023. [PMID: 33415074 DOI: 10.3389/fonc.2020.592023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
19 Zuo R, Zhang C, Lin L, Meng Z, Wang Y, Su Y, Abudurazik M, Du Y, Chen P. Durable efficacy of anlotinib in a patient with advanced thymic squamous cell carcinoma after multiline chemotherapy and apatinib: A case report and literature review. Thorac Cancer 2020;11:3383-7. [PMID: 32997432 DOI: 10.1111/1759-7714.13658] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
20 Zeng H, Yang W, Xu B, Zou J, Su C, Zhong B, Zhu H, Chen Z. Relationship of possible biomarkers with malignancy of thymic tumors: a meta-analysis. BMC Cancer 2020;20:928. [PMID: 32993581 DOI: 10.1186/s12885-020-07332-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
21 Kemper M, Moradzadeh M, Bellon E, Bahar AS, Grotelüschen R, Reeh M, Izbicki JR, Bachmann K. A single-center experience: management of patients with thymic epithelial tumors. World J Surg Oncol 2020;18:202. [PMID: 32791986 DOI: 10.1186/s12957-020-01988-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Rai M, Keogh A. A Rare Case of a High-Grade Thymic Squamous Cell Carcinoma Presenting as Cardiac Tamponade. Cureus 2020;12:e9366. [PMID: 32850235 DOI: 10.7759/cureus.9366] [Reference Citation Analysis]
23 Ye C, Bao M, Li H, Liu X, Jiang G, Wang W. Surgery in Masaoka stage IV thymic carcinoma: a propensity-matched study based on the SEER database. J Thorac Dis 2020;12:659-71. [PMID: 32274131 DOI: 10.21037/jtd.2019.12.111] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Kalhor N, Weissferdt A, Moran CA. Thoracic Pathology. Oncological Surgical Pathology 2020. [DOI: 10.1007/978-3-319-96681-6_11] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
25 Weissferdt A. Thymic Epithelial Neoplasms. Diagnostic Thoracic Pathology 2020. [DOI: 10.1007/978-3-030-36438-0_28] [Reference Citation Analysis]
26 Bale M, Parshad R. Surgical Approach to Thymic Lesions. Atlas of Thymic Pathology 2020. [DOI: 10.1007/978-981-15-3164-4_4] [Reference Citation Analysis]
27 Wang B, Li K, Song QK, Wang XH, Yang L, Zhang HL, Zhong DR. Micronodular thymic tumor with lymphoid stroma: A case report and review of the literature. World J Clin Cases 2019; 7(23): 4063-4074 [PMID: 31832410 DOI: 10.12998/wjcc.v7.i23.4063] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
28 Ströbel P, Marx A. Thymus. Pathologie 2019. [DOI: 10.1007/978-3-540-85184-4_39] [Reference Citation Analysis]
29 Kalhor N, Moran C. Staging for Thymoma and Thymic Carcinoma. Mediastinal Pathology 2019. [DOI: 10.1007/978-3-319-98980-8_6] [Reference Citation Analysis]
30 Kalhor N, Moran C. Thymic Carcinoma. Mediastinal Pathology 2019. [DOI: 10.1007/978-3-319-98980-8_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
31 Yudong S, Zhaoting M, Xinyue W, Li L, Xiaoyan X, Ran Z, Jinliang C, Peng C. EGFR exon 20 insertion mutation in advanced thymic squamous cell carcinoma: Response to apatinib and clinical outcomes. Thorac Cancer 2018;9:885-91. [PMID: 29740957 DOI: 10.1111/1759-7714.12755] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
32 Dai X, Zhao L, Peng F. Primary clear cell carcinoma of the thymus and literature comparison of features. Cancer Manag Res 2018;10:513-8. [PMID: 29588619 DOI: 10.2147/CMAR.S158452] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
33 Rossi G, Ragazzi M, Cavazza A. Diagnostic Histopathology Approach. Current Clinical Pathology 2018. [DOI: 10.1007/978-3-319-90368-2_6] [Reference Citation Analysis]
34 Ruffini E, Weder W, Filosso PL, Girard N. Thymic Tumors. IASLC Thoracic Oncology 2018. [DOI: 10.1016/b978-0-323-52357-8.00056-1] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
35 Liu Q, Fu X, Su X, Wang X, Zhang Y, Yang H, Hu Y, Wen J, Fu J. Elevated pretreatment serum lactate dehydrogenase level predicts inferior overall survival and disease-free survival after resection of thymic carcinoma. J Thorac Dis 2017;9:4550-60. [PMID: 29268525 DOI: 10.21037/jtd.2017.10.86] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
36 Chen Y, Liu X, Liu Y, Wang Y, Wang H, Lu C, Zhang P. Decreased Wnt4 expression inhibits thymoma development through downregulation of FoxN1. J Thorac Dis 2017;9:1574-83. [PMID: 28740671 DOI: 10.21037/jtd.2017.05.28] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
37 Mlika M, Mezni F. Review of the literature about Thymic Carcinomas. Arch Pulmonol Respir Care 2017;3:058-066. [DOI: 10.17352/aprc.000027] [Reference Citation Analysis]
38 Abu Zaid M, Kesler K, Smith J, Badve S, Loehrer PJ. Thymoma and Thymic Carcinoma. Textbook of Uncommon Cancer 2017. [DOI: 10.1002/9781119196235.ch14] [Reference Citation Analysis]
39 Jiang Y, Liu Y, Shi X, Mao X, Zhao Y, Fan C. An unusual combined thymic carcinoma composed of squamous cell carcinoma and type AB thymoma: a rare case report. Diagn Pathol 2017;12:9. [PMID: 28095872 DOI: 10.1186/s13000-016-0590-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
40 Leisibach P, Schneiter D, Soltermann A, Yamada Y, Weder W, Jungraithmayr W. Prognostic value of immunohistochemical markers in malignant thymic epithelial tumors. J Thorac Dis. 2016;8:2580-2591. [PMID: 27747012 DOI: 10.21037/jtd.2016.08.82] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
41 Weissferdt A, Kalhor N, Moran CA. Thymomas With Extensive Clear Cell Component:  A Clinicopathologic and Immunohistochemical Study of Nine Cases. Am J Clin Pathol 2016;146:132-6. [PMID: 27371363 DOI: 10.1093/ajcp/aqw094] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
42 Wu J, Fang W, Chen G. The enlightenments from ITMIG Consensus on WHO histological classification of thymoma and thymic carcinoma: refined definitions, histological criteria, and reporting. J Thorac Dis. 2016;8:738-743. [PMID: 27114842 DOI: 10.21037/jtd.2016.01.84] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 2.2] [Reference Citation Analysis]
43 Litvak AM, Woo K, Hayes S, Huang J, Rimner A, Sima CS, Moreira AL, Tsukazan M, Riely GJ. Clinical characteristics and outcomes for patients with thymic carcinoma: evaluation of Masaoka staging. J Thorac Oncol 2014;9:1810-5. [PMID: 25393794 DOI: 10.1097/JTO.0000000000000363] [Cited by in Crossref: 39] [Cited by in F6Publishing: 46] [Article Influence: 5.6] [Reference Citation Analysis]
44 Zhang H, Zhang P, Liu Y, Lv P, Wang Y, Chen Y. In vitro study of the effect of small interfering ribonucleic acid on the expression of FOXN1 and B cell-attracting chemokine 1 in thymoma cell lines. Thorac Cancer 2015;6:172-9. [PMID: 26273355 DOI: 10.1111/1759-7714.12160] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
45 Li W, Miao Z, Liu X, Zhang Q, Sun L, Li P, Liu W, Zhang L. Thymic carcinoma patients with myasthenia gravis exhibit better prognoses. Int J Clin Oncol 2016;21:75-80. [PMID: 26138264 DOI: 10.1007/s10147-015-0862-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
46 Wu JX, Chen HQ, Shao LD, Qiu SF, Ni QY, Zheng BH, Wang JZ, Pan JJ, Li JL. Long-term follow-up and prognostic factors for advanced thymic carcinoma. Medicine (Baltimore) 2014;93:e324. [PMID: 25526488 DOI: 10.1097/MD.0000000000000324] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
47 Wick MR, Moran CA, Marchevsky AM, Powers CN, Wakely PE. Surgical pathology and cytopathology of the thymus and mediastinum. Silverberg's Principles and Practice of Surgical Pathology and Cytopathology 2015. [DOI: 10.1017/9781139137201.022] [Reference Citation Analysis]
48 Wick MR, Marchevsky AM, Suster S. High-grade malignant epithelial tumors of the thymus: primary thymic carcinomas. Pathology of the Mediastinum 2015. [DOI: 10.1017/cbo9781316160824.008] [Reference Citation Analysis]
49 Wang YF, Liu B, Fan XS, Rao Q, Xu Y, Xia QY, Yu B, Shi SS, Zhou XJ. Thyroid carcinoma showing thymus-like elements: a clinicopathologic, immunohistochemical, ultrastructural, and molecular analysis. Am J Clin Pathol 2015;143:223-33. [PMID: 25596248 DOI: 10.1309/AJCPB7PS6QHWEFRK] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
50 Ibuki Y, Okami J, Tomita Y, Fujiwara A, Kanou T, Tokunaga T, Higashiyama M. Primary papillary carcinoma of the thymus with invasion into subcutaneous tissue through the sternum. J Cardiothorac Surg 2014;9:77. [PMID: 24885502 DOI: 10.1186/1749-8090-9-77] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
51 Weissferdt A, Moran CA. Staging of primary mediastinal tumors. Adv Anat Pathol 2013;20:1-9. [PMID: 23232566 DOI: 10.1097/PAP.0b013e31827b6619] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
52 Tumors of the lung and mediastinum. Modern Immunohistochemistry 2000. [DOI: 10.1017/cbo9781316167366.004] [Reference Citation Analysis]